carvedilol has been researched along with enrasentan in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clark, A; Cleland, JG; Crabbe, S; Ford, S; Houghton, T; Louis, A; Thackray, S | 1 |
1 review(s) available for carvedilol and enrasentan
| Article | Year |
|---|---|
Clinical Trials Update: CAPRICORN, COPERNICUS, MIRACLE, STAF, RITZ-2, RECOVER and RENAISSANCE and cachexia and cholesterol in heart failure. Highlights of the Scientific Sessions of the American College of Cardiology, 2001.
Topics: Adrenergic beta-Antagonists; Atrial Fibrillation; Cachexia; Carbazoles; Carboxylic Acids; Carvedilol; Cholesterol; Cytokines; Endothelins; Heart Failure; Humans; Indans; Injections, Intravenous; Myocardial Infarction; Propanolamines; Pyridines; Tetrazoles; United States; Vasodilator Agents | 2001 |
1 trial(s) available for carvedilol and enrasentan
| Article | Year |
|---|---|
Clinical Trials Update: CAPRICORN, COPERNICUS, MIRACLE, STAF, RITZ-2, RECOVER and RENAISSANCE and cachexia and cholesterol in heart failure. Highlights of the Scientific Sessions of the American College of Cardiology, 2001.
Topics: Adrenergic beta-Antagonists; Atrial Fibrillation; Cachexia; Carbazoles; Carboxylic Acids; Carvedilol; Cholesterol; Cytokines; Endothelins; Heart Failure; Humans; Indans; Injections, Intravenous; Myocardial Infarction; Propanolamines; Pyridines; Tetrazoles; United States; Vasodilator Agents | 2001 |